EA200000994A1 - Применение кабэрголина при лечении синдрома усталых ног - Google Patents

Применение кабэрголина при лечении синдрома усталых ног

Info

Publication number
EA200000994A1
EA200000994A1 EA200000994A EA200000994A EA200000994A1 EA 200000994 A1 EA200000994 A1 EA 200000994A1 EA 200000994 A EA200000994 A EA 200000994A EA 200000994 A EA200000994 A EA 200000994A EA 200000994 A1 EA200000994 A1 EA 200000994A1
Authority
EA
Eurasian Patent Office
Prior art keywords
kabergolin
application
treating syndrome
tired
foot
Prior art date
Application number
EA200000994A
Other languages
English (en)
Other versions
EA002554B1 (ru
Inventor
Петер Шулер
Original Assignee
Фармация Энд Апджон Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фармация Энд Апджон Компани filed Critical Фармация Энд Апджон Компани
Publication of EA200000994A1 publication Critical patent/EA200000994A1/ru
Publication of EA002554B1 publication Critical patent/EA002554B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Настоящее изобретение предоставляет применение кабэрголина и других средств для лечения синдрома усталых ног (СУН).Отчет о международном поиске был опубликован 1999.11.25.
EA200000994A 1998-03-27 1999-03-24 Применение кабэрголина при лечении синдрома усталых ног EA002554B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7963998P 1998-03-27 1998-03-27
PCT/US1999/004269 WO1999048484A2 (en) 1998-03-27 1999-03-24 Use of cabergoline in the treatment of restless legs syndrome

Publications (2)

Publication Number Publication Date
EA200000994A1 true EA200000994A1 (ru) 2001-02-26
EA002554B1 EA002554B1 (ru) 2002-06-27

Family

ID=22151836

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000994A EA002554B1 (ru) 1998-03-27 1999-03-24 Применение кабэрголина при лечении синдрома усталых ног

Country Status (23)

Country Link
US (1) US6114326A (ru)
EP (1) EP1066038B1 (ru)
JP (1) JP2002507562A (ru)
KR (1) KR100597517B1 (ru)
CN (1) CN1303286A (ru)
AT (1) ATE313326T1 (ru)
AU (1) AU747751B2 (ru)
BR (1) BR9908953A (ru)
CA (1) CA2320204A1 (ru)
CZ (1) CZ297284B6 (ru)
DE (1) DE69929041T2 (ru)
DK (1) DK1066038T3 (ru)
EA (1) EA002554B1 (ru)
ES (1) ES2255255T3 (ru)
HU (1) HUP0101954A3 (ru)
IL (1) IL138522A0 (ru)
NO (1) NO20004799L (ru)
NZ (1) NZ507176A (ru)
PL (1) PL343593A1 (ru)
SK (1) SK13312000A3 (ru)
TR (1) TR200002759T2 (ru)
WO (1) WO1999048484A2 (ru)
ZA (1) ZA200004452B (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2698728C1 (ru) * 2015-12-09 2019-08-29 Офта Сп. З О.О. Применение каберголина в лечении патологических состояний, вызванных повышенными уровнями фактора роста эндотелия сосудов

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
PT1685839E (pt) 1997-12-22 2013-07-08 Euro Celtique Sa Forma de dosagem farmacêutica por via oral compreendendo uma combinação de um agonista opióide e de um antagonista opióide
US6477408B1 (en) * 2000-03-07 2002-11-05 Northwestern University Analysis of muscular activity in neonatal animals to screen for mutations and/or drugs that alter sleep and wake states
GB0007309D0 (en) * 2000-03-24 2000-05-17 Pharmacia & Upjohn Spa Crystalline form V|| of cabergoline
GB0007308D0 (en) 2000-03-24 2000-05-17 Pharmacia & Upjohn Spa Process for preparing crystalline form | of cabergoline
US6426713B1 (en) * 2000-07-05 2002-07-30 Cirrus Logic, Inc. Independent control of calibration registers in a multi channel A-D converter
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10066158B4 (de) * 2000-08-24 2007-08-09 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms
AR031152A1 (es) * 2000-10-31 2003-09-10 Upjohn Co Tratamientos nuevos para el sindrome de piernas inquietas
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US20020123503A1 (en) * 2000-12-21 2002-09-05 Malcolm Ross Cabergoline pharmaceutical compositions and methods of use thereof
CN100398154C (zh) * 2001-03-30 2008-07-02 东丽株式会社 精神神经疾病治疗药
DE60238756D1 (de) 2001-05-11 2011-02-10 Endo Pharmaceuticals Inc Opioid enthaltende arzneiform gegen missbrauch
US20030134844A1 (en) * 2001-10-31 2003-07-17 Pfizer Inc. Nicontinic acetylcholine receptor antagonists in the treatment of restless legs syndrome
US20030176822A1 (en) * 2002-03-12 2003-09-18 Morgenlander Joel C. Method of treating restless leg syndrome
DE20308437U1 (de) * 2002-04-05 2003-11-13 Euroceltique S.A., Luxemburg/Luxembourg Matrix zur verzögerten, gleichbleibenden und unabhängigen Freisetzung von Wirkstoffen
US20040048779A1 (en) * 2002-05-06 2004-03-11 Erwin Schollmayer Use of rotigotine for treating the restless leg syndrome
CN1671390A (zh) 2002-08-30 2005-09-21 协和发酵工业株式会社 用于治疗多动腿综合症或相关疾病的腺苷a2a受体拮抗剂
NZ545989A (en) 2003-09-17 2009-10-30 Xenoport Inc Treating or preventing restless legs syndrome using prodrugs of gaba analogs
EP1604666A1 (en) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
EP1604667A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the restless leg syndrome
KR20060030175A (ko) * 2004-10-05 2006-04-10 경북대학교 산학협력단 무정위성 운동 치료용 약학조성물
EP1771160A2 (en) * 2005-01-28 2007-04-11 Euroceltique S.A. Alcohol resistant dosage forms
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
EP1695700A1 (en) * 2005-02-28 2006-08-30 Euro-Celtique S.A. Dosage form containing oxycodone and naloxone
AU2006337137B2 (en) * 2005-12-29 2012-06-14 Tersera Therapeutics Llc Multicyclic amino acid derivatives and methods of their use
WO2007117431A2 (en) * 2006-04-03 2007-10-18 Teva Pharmaceutical Industries, Ltd. Use of rasagiline for the treatment of restless legs syndrome
WO2008046149A1 (en) * 2006-10-17 2008-04-24 Biologic Health Solutions Pty Ltd Herbal compositions for the prevention or treatment of restless leg syndrome
EP1952813A1 (en) * 2007-02-01 2008-08-06 Ferring International Center S.A. Medicament for the treatment of endometriosis
EP1987815A1 (en) * 2007-05-04 2008-11-05 Schwarz Pharma Ag Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders
US7939665B2 (en) 2007-05-04 2011-05-10 Apotex Pharmachem Inc. Efficient process for the preparation of cabergoline and its intermediates
EP2083008A1 (en) * 2007-12-07 2009-07-29 Axxonis Pharma AG Ergoline derivatives as selective radical scavengers for neurons
PT2405915T (pt) 2009-03-10 2019-01-29 Euro Celtique Sa Composições farmacêuticas de libertação imediata compreendendo oxicodona e naloxona
DK2413912T3 (da) 2009-04-01 2019-06-17 Bial Portela & Ca Sa Farmaceutiske formuleringer, der omfatter nitrocatecholderivater, og metoder til fremstilling deraf
US8690933B2 (en) * 2009-08-31 2014-04-08 Brigham Young University System and method for treating symptoms of restless legs syndrome
NZ716267A (en) 2013-07-23 2017-05-26 Euro Celtique Sa A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
CN110603073B (zh) 2017-01-05 2023-07-04 诺克特丽克丝健康公司 不宁腿综合征或过度活跃神经治疗
US11103691B2 (en) 2019-10-03 2021-08-31 Noctrix Health, Inc. Peripheral nerve stimulation for restless legs syndrome

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526892A (en) * 1981-03-03 1985-07-02 Farmitalia Carlo Erba, S.P.A. Dimethylaminoalkyl-3-(ergoline-8'βcarbonyl)-ureas
US5496836A (en) * 1994-05-05 1996-03-05 Mount Sinai School Of Medicine Of The City University Of New York Use of famotidine and related compounds in the treatment of movement disorders

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2698728C1 (ru) * 2015-12-09 2019-08-29 Офта Сп. З О.О. Применение каберголина в лечении патологических состояний, вызванных повышенными уровнями фактора роста эндотелия сосудов

Also Published As

Publication number Publication date
AU747751B2 (en) 2002-05-23
EA002554B1 (ru) 2002-06-27
CZ297284B6 (cs) 2006-10-11
EP1066038B1 (en) 2005-12-21
ES2255255T3 (es) 2006-06-16
NZ507176A (en) 2003-09-26
KR20010052222A (ko) 2001-06-25
DK1066038T3 (da) 2006-04-24
CZ20003419A3 (cs) 2002-01-16
ATE313326T1 (de) 2006-01-15
BR9908953A (pt) 2000-12-05
JP2002507562A (ja) 2002-03-12
HUP0101954A3 (en) 2002-09-30
WO1999048484A2 (en) 1999-09-30
CA2320204A1 (en) 1999-09-30
SK13312000A3 (sk) 2001-05-10
NO20004799L (no) 2000-10-11
CN1303286A (zh) 2001-07-11
US6114326A (en) 2000-09-05
PL343593A1 (en) 2001-08-27
EP1066038A2 (en) 2001-01-10
IL138522A0 (en) 2001-10-31
WO1999048484A3 (en) 1999-11-25
NO20004799D0 (no) 2000-09-26
AU3353199A (en) 1999-10-18
DE69929041D1 (de) 2006-01-26
TR200002759T2 (tr) 2001-02-21
ZA200004452B (en) 2002-02-27
HUP0101954A2 (hu) 2001-12-28
KR100597517B1 (ko) 2006-07-10
DE69929041T2 (de) 2006-07-20

Similar Documents

Publication Publication Date Title
EA200000994A1 (ru) Применение кабэрголина при лечении синдрома усталых ног
EA199900168A1 (ru) Применение glp-1 или его аналогов в лечении инфаркта миокарда
ATE265213T1 (de) Noribogain zur behandlung von schmerzen und drogenabhängigkeit
SE9404196D0 (sv) New antithrombotic formulation
FR2786664B1 (fr) Procede de traitement de fruits et legumes utilisant l'eugenol et/ou l'isoeugenol et utilisation d'une composition a base d'eugenol et/ou d'isoeugenol
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
DE60132444D1 (de) Behandlung von reizkolon-syndrom oder -krankheit
SE9603725D0 (sv) New teatment
AU6083301A (en) Treating eczema and/or psoriasis
ATE195414T1 (de) Kompresionsstrumpf oder -strumpfhose
PT1076540E (pt) Ligadura de compressao
SE9601395D0 (sv) New therapeutic treatment 1
MX9805506A (es) Uso medico novedoso de un inhibidor de la dispepsia relacionada con acido para el tratamiento de sintomas dispepticos.
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
NO993360D0 (no) Anvendelse av pramipeksol ved behandling av "restless leg"- syndromet
ATE291918T1 (de) Kombinationstherapie zur behandlung von tumoren
MY124071A (en) Treatment of viral disease in swine
ES2190581T3 (es) 2-aminotetralina opticamente activa, procedimiento para su preparacion y composiciones farmaceuticas que la contienen, activa en la prevencion y tratamiento de shock septico.
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
NO984196L (no) FremgangsmÕte for behandling av stoffmisbruk
ATE271867T1 (de) Behandlung der harninkontinenz und zusammenstellung dafür
DE69635282D1 (de) Behandlung der exzessiven aggressivität mit olanzapine
EA199800818A1 (ru) Способ лечения бессонницы
UA9706A (ru) Устройство для лечения импотенции
GB2313036A (en) Sheepwool insole

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU